Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Fractyl Health, Inc./ 10-Q

Quarterly Report · 10-Q

Fractyl Health, Inc.

GUTSNASDAQEQUITYCurrent

Quarterly Report

Filed Aug 10, 2026Accepted Aug 10, 2026, 4:05 PM EDTCIK 1572616Accession 0001193125-26-342345
View company →Permanent SEC source ↗
Share

Company context

Fractyl is a clinical-stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes. The Company’s lead product candidate, Revita, is an endoscopic procedural therapy in pivotal development for post-GLP-1 weight maintenance. Fractyl’s goal is to change the course of metabolic disease, advancing treatment from chronic management toward prevention and reversal of disease. Fractyl is headquartered in Burlington, Massachusetts.

Current securities

GUTSNASDAQ · EQUITY · Current

Recent company filings

  1. Costs Associated with Exit or Disposal Activities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsOct 22, 2026
  2. Regulation FD Disclosure · Other EventsOct 16, 2026
  3. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearOct 1, 2026
  4. Submission of Matters to a Vote of Security HoldersSep 24, 2026
  5. 4 filingSep 16, 2026

Registered securities in this filing

Fractyl Health, Inc. · 10-Q · Filed 2026-08-10

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, $0.00001 par value per share

Symbol
GUTS
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: C_b67e7c09-ad62-4a14-bfa0-d845f814479b

Dimensions: Not supplied

Accession 000119312526342345 · 1 registered-security cover member

Read the exact SEC filing ↗

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.